Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM - Contacts and Locations

Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM (TESSTAL)

This study is ongoing, but not recruiting participants.

Study NCT00490789. Last updated on April 29, 2008. Information provided by Cardiff University

Please refer to this study by its ClinicalTrials.gov identifier: NCT00490789

Locations


United Kingdom
	City Hospital
	Nottingham, United Kingdom, NG5 1PB
	Royal Sussex County Hospital
	Brighton, United Kingdom, BN2 5BE

United Kingdom, Wales
	University Hospital of Wales
	Cardiff, Wales, United Kingdom, CF14 4XN

Sponsors and Collaborators

Cardiff University

University of Nottingham

St Georges Hospital Medical School

Royal Sussex County Hospital

Wales Gene Park

The Tuberous Sclerosis Association

Wyeth

Investigators


Principal Investigator:	Julian R Sampson, DM	Cardiff Univeristy